Cystic echinococcosis of the liver in the Autonomous Province of Vojvodina, Serbia: Challenges in clinical practice
Vojnosanitetski pregled · 2026 · (00) · 62-62
DOI: 10.2298/vsp260203062d ↗Abstract
Background/Aim. Cystic echinococcosis (CE) of the liver represents a significant health and economic burden in endemic regions, with a rising incidence in the Autonomous Province of Vojvodina, Serbia. The aim of the study was to investigate the therapeutic modalities applied in patients with hepatic CE treated at the University Clinical Center of Vojvodina over an 11-year period, compare their outcomes, and analyze indirect indicators of economic burden. Methods. A retrospective analysis was conducted, including 90 patients with hepatic CE diagnosed and/or treated at the University Clinical Center of Vojvodina between 2013 and 2024. Diagnosis was based on epidemiological data, serological testing, and imaging methods, with liver cysts classified according to World Health Organization criteria. Patients were stratified into five groups according to the therapeutic approach, and treatment modalities were analyzed in relation to the number and length of hospitalizations, cyst stage, antibody titer, and the number of albendazole courses. Results. Women comprised the majority of patients (n = 53; 59%; p < 0.001), with a mean age of 55 years (range: 16-86 years). The mean length of hospital stay was 32.82 days and did not differ significantly according to the treatment modality (p = 0.071). The number of hospitalizations was significantly higher in patients treated with invasive methods (surgery/puncture, aspiration, injection, and re-aspiration - PAIR; p < 0.001). The majority of patients was treated with combination therapy: surgery with albendazole (22/90) or albendazole combined with PAIR (19/90). The highest percentage of patients (25.6%) received a single course of albendazole, whereas the number of albendazole courses differed significantly according to therapeutic approach (p < 0.01). Cyst stage and antibody titer showed no significant association with treatment choice (p = 0.087; p = 0.891). Conclusion. A national protocol incorporating established international criteria, with routine serological screening and a structured two-year follow-up, could be useful in the future care of patients with hepatic CE.
EUVIMED